Praxis Precision Medicines Stock News & Updates

[WKN: A3EW9Y | Symbol: PRAX]

Praxis Precision Medicines

Praxis Precision Medicines: Between FDA Approval and Billion-Dollar Market

02/02/2026 at 01 PM

RWE [DE0007037129] Goldman Sachs confirms Buy rating and raises the price target from €53.50 to €60...

12/12/2025 at 05 PM

Business drivers: Praxis Precision Medicines (PRAX) specializes in the development of therapies for...

12/05/2025 at 03 PM

Praxis Precision Medicines Inc. (PRAX) is a biotechnology company that specializes in developing therapies...

11/19/2025 at 04 PM

Praxis Precision Medicines (PRAX) is a biopharmaceutical company focused on developing novel therapies...

11/13/2025 at 01 PM

On Holding [CH1134540470] UBS reiterates its Buy Rating and raises the price target from $79 to $85...

10/17/2025 at 04 PM

Praxis Precision Medicines Inc. (PRAX) specializes in the development of therapies for central nervous...

10/17/2025 at 03 PM

Praxis Precision Medicines (PRAX) is a clinical-stage biopharmaceutical company that translates insights...

10/17/2025 at 11 AM

Array Technologies [US04271T1007] JPMorgan maintains Overweight rating and raises price target from...

06/12/2025 at 01 PM

SoFi Technologies [US83406F1021]: Stephens starts coverage with Overweight and a price target of $20...